Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Uterine Cervical Neoplasms 1Testicular Neoplasms 1Seminoma 1Neoplasms 1Hearing Loss 1Adenocarcinoma 1

Interventions

Filgrastim 4Carboplatin 4Peripheral Blood Stem Cell Transplantation 3Magnetic Resonance Spectroscopy 3Granulocyte Colony-Stimulating Factor 3Etoposide 3Busulfan 3aflibercept 2Trastuzumab 2Temozolomide 2Radiotherapy 2Polymerase Chain Reaction 2Melphalan 2Interleukin-12 Subunit p35 2Fluorodeoxyglucose F18 2Flow Cytometry 2FAPI-46 2Cyclophosphamide 2Bone Marrow Transplantation 2veliparib 1trioctyl phosphine oxide 1tipifarnib 1sodium thiosulfate 1sargramostim 1ixabepilone 1isophosphamide mustard 1guadecitabine 1fludarabine phosphate 1entinostat 1claudin 6 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Testicular Neoplasms × Hearing × Clear all
NCT07218913 2026-04-17

Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors

City of Hope Medical Center

Phase 1 Recruiting
44 enrolled
Genitourinary

Testicular Neoplasms, Seminoma, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡